Maternal serum CA125 levels in early intrauterine and tubal pregnancies
β Scribed by F. Kobayashi; E. Takashima; N. Sagawa; T. Mori; S. Fujii
- Publisher
- Springer
- Year
- 1993
- Tongue
- English
- Weight
- 372 KB
- Volume
- 252
- Category
- Article
- ISSN
- 0003-9128
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In a study of amniotic fluid from 91 Down syndrome cases and 240 controls, we have shown that the median value of CA125 in pregnancies affected by Down syndrome on the whole reflects those observed in the maternal serum from 106 affected cases and 238 controls. The median MOM for CA125 in amniotic f
Inhibin A is now an established second-trimester maternal serum marker of Down syndrome. Since activin A has a common -subunit to inhibin A we evaluated this substance and its binding protein, follistatin, as potential markers. We studied 30 affected and 199 unaffected pregnancies at 13-16 weeks' ge
correctly normalize urine data. The tighter distribution of hyperglycosylated hCG measurements in serum may compensate for the lesser elevation of values in Down syndrome cases. Hyperglycosylated hCG determinations might be equally useful in urine and serum samples. 60 per cent sensitivity is sugges